ANEES BANDAY to Insulin
This is a "connection" page, showing publications ANEES BANDAY has written about Insulin.
Connection Strength
1.148
-
Chronic insulin treatment phosphorylates the renal Na-K-ATPase a1-subunit at serine 16/23 and reduces its activity involving PI3-kinase-dependent PKC activation. Am J Physiol Renal Physiol. 2016 11 01; 311(5):F958-F966.
Score: 0.367
-
Insulin causes renal dopamine D1 receptor desensitization via GRK2-mediated receptor phosphorylation involving phosphatidylinositol 3-kinase and protein kinase C. Am J Physiol Renal Physiol. 2007 Sep; 293(3):F877-84.
Score: 0.193
-
Tempol reduces oxidative stress, improves insulin sensitivity, decreases renal dopamine D1 receptor hyperphosphorylation, and restores D1 receptor-G-protein coupling and function in obese Zucker rats. Diabetes. 2005 Jul; 54(7):2219-26.
Score: 0.169
-
Insulin treatment enhances AT1 receptor function in OK cells. Am J Physiol Renal Physiol. 2005 Jun; 288(6):F1213-9.
Score: 0.165
-
Dopamine-mediated inhibition of renal Na,K-ATPase is reduced by insulin. Hypertension. 2003 Jun; 41(6):1353-8.
Score: 0.145
-
Exercise reduces oxidative stress but does not alleviate hyperinsulinemia or renal dopamine D1 receptor dysfunction in obese rats. Am J Physiol Renal Physiol. 2011 Jan; 300(1):F98-104.
Score: 0.061
-
Renal dopamine D(1) receptor dysfunction is acquired and not inherited in obese Zucker rats. Am J Physiol Renal Physiol. 2004 Jul; 287(1):F109-16.
Score: 0.039
-
Rosiglitazone treatment restores renal dopamine receptor function in obese Zucker rats. Hypertension. 2002 Dec; 40(6):880-5.
Score: 0.009